Tilray Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Inc
CVGW Calavo Growers Inc
MSFT Microsoft Corp
TWO Two Harbors Investment Corp
PTIE Pain Therapeutics Inc
NGL NGL Energy Partners LP
AMID American Midstream Partners LP
SPH Suburban Propane Partners LP
SGU Star Group LP
FGP Ferrellgas Partners LP
Go

Health Care : Pharmaceuticals |
Based in CanadaCompany profile

Tilray Inc is a Canada-based company engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

New! Enhance the way you research investment opportunities with Social Signals, a one of a kind trading resource that pulls insights from Twitter.

Price: Delayed
$83.66

Day's Change: 0.78 (0.94%)

Bid: --

Ask: --

B/A Size: --

Day's High: 87.62

Day's Low: 81.90

Volume (Heavy Day) Today's volume of 3,279,539 shares is on pace to be much greater than TLRY's 10-day average volume of 4,889,851 shares.: 3,279,539

There is no peer information for TLRY.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.